Bibliometric analysis of sacubitril/valsartan in the management of chronic kidney disease (2013-2025) - PubMed
6 hours ago
- #bibliometric-analysis
- #chronic-kidney-disease
- #sacubitril-valsartan
- A bibliometric analysis evaluated 254 articles on sacubitril/valsartan in chronic kidney disease (CKD) from 2013 to 2025.
- Publications have increased steadily, with China and the United States as leading contributors; the U.S. showed higher betweenness centrality.
- Key productive sources included Novartis, Harvard University, and ESC Heart Failure journal.
- Emerging research themes involve combination therapy with SGLT2 inhibitors, precision medicine, and applications in cardiorenal syndrome and end-stage renal disease.
- Gaps identified include long-term safety, dialysis dosing, and renoprotective mechanisms, guiding future clinical research.